Fredag 20 Mars | 02:57:39 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2027-02-25 08:30 Bokslutskommuniké 2026
2026-11-26 08:30 Kvartalsrapport 2026-Q3
2026-08-27 08:30 Kvartalsrapport 2026-Q2
2026-06-18 N/A X-dag ordinarie utdelning AXIC A 0.00 SEK
2026-06-17 N/A Årsstämma
2026-05-21 08:30 Kvartalsrapport 2026-Q1
2026-02-26 - Bokslutskommuniké 2025
2025-11-28 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-06-19 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2025-06-18 - Årsstämma
2025-05-22 - Kvartalsrapport 2025-Q1
2025-02-27 - Bokslutskommuniké 2024
2024-11-28 - Kvartalsrapport 2024-Q3
2024-08-27 - Kvartalsrapport 2024-Q2
2024-06-20 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2024-06-19 - Årsstämma
2024-05-23 - Kvartalsrapport 2024-Q1
2024-03-06 - Extra Bolagsstämma 2024
2024-03-05 - Bokslutskommuniké 2023
2023-11-22 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-06-19 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2023-06-16 - Årsstämma
2023-05-24 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2022-05-31 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-31 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2021-05-28 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-24 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-27 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2020-05-26 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-05-29 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2019-05-28 - Årsstämma
2019-05-23 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-15 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2018-05-31 - Årsstämma
2018-05-15 - Kvartalsrapport 2018-Q1
2018-02-27 - Bokslutskommuniké 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2017-05-31 - Årsstämma
2017-05-31 - Kvartalsrapport 2017-Q1
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-24 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2016-05-23 - Årsstämma
2016-05-19 - Kvartalsrapport 2016-Q1
2016-02-25 - Bokslutskommuniké 2015
2015-11-25 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-29 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2015-05-28 - Årsstämma
2015-05-25 - Kvartalsrapport 2015-Q1
2015-02-26 - Bokslutskommuniké 2014
2014-11-24 - Kvartalsrapport 2014-Q3
2014-08-28 - Kvartalsrapport 2014-Q2
2014-05-22 - Årsstämma
2014-05-22 - Kvartalsrapport 2014-Q1
2014-02-28 - Bokslutskommuniké 2013
2013-11-29 - Kvartalsrapport 2013-Q3
2013-08-26 - Kvartalsrapport 2013-Q2
2013-06-28 - Split AXIC A 4:1
2013-05-30 - Kvartalsrapport 2013-Q1
2013-05-21 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2013-05-20 - Årsstämma
2013-02-28 - Bokslutskommuniké 2012
2012-11-26 - Kvartalsrapport 2012-Q3
2012-08-30 - Kvartalsrapport 2012-Q2
2012-05-28 - Kvartalsrapport 2012-Q1
2012-05-17 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2012-05-16 - Årsstämma
2012-02-29 - Bokslutskommuniké 2011
2011-11-28 - Kvartalsrapport 2011-Q3
2011-08-30 - Kvartalsrapport 2011-Q2
2011-05-30 - Kvartalsrapport 2011-Q1
2011-05-10 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2011-05-09 - Årsstämma
2011-02-25 - Bokslutskommuniké 2010
2010-05-11 - X-dag ordinarie utdelning AXIC A 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriPlast, kemikalier & fetter
aXichem är verksamt inom industriell bioteknik. Bolaget utvecklar, patenterar och marknadsför industrikemikalier. Bolaget arbetar huvudsakligen med Fenylcapsaicin, en naturanalog syntetisk capsaicin med tillämpningar inom en mängd olika områden, såsom inom den marina sektorn, bland skadedjursbekämpning i skogs-och jordbruk, samt bland enskilda farmaceutiska arbetsområden. Verksamhet drivs på global nivå, med huvudkontor i Malmö.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-18 08:30:00

aXichem AB (publ), (aXichem), a developer of innovative natural analogue feed additives and dietary supplement ingredients, announces that the company has obtained product registration in Brazil for phenylcapsaicin as an additive in feed for dairy cows.

The background to the product registration is the, previously communicated, promising initial findings in an exploratory field evaluation carried out in Brazil with aXiphen® administered in the feed to Girolando dairy cattle, findings that was later confirmed by data from a 90-day controlled trial, assessing aXiphen® in lactating Jersey cows, measuring daily milk volume and standard composition under real-farm conditions. Based on the impressive data, Chr. Olesen's team decided to submit a fast-track registration of phenylcapsaicin as an additive in feed for dairy cows. The review process is now concluded by the authorities and phenylcapsaicin is thereby registered in Brazil as a feed additive for ruminant animals, as well as for poultry and swine.

Torsten Helsing, CEO, comments:
"We are pleased with the determination and enthusiasm that the Chr. Olesen team in Brazil has put into the process of the evaluation of aXiphen for the dairy market and to get the registration of the product to happen. I'm looking forward to the continued collaboration with the team and to introduce aXiphen in this new market segment of animal feed."

Rafael Silva, Managing Partner at Chr. Olesen Latin America A/S, comments:
"Our team is very excited to start the commercial launch of aXiphen in the dairy cow feed segment. The initial interest from farmers was driving force to getting the product registered and ready for commercial sales. With the impressive data from the trials to support we are now ready to go to work."

About the trials with aXiphen® (phenylcapsaicin)
aXiphen was included in an exploratory field test in Brazil with Girolando cows, initiated by a dairy producer with an excellent production of about 39 liters per cow per day. In the test 54 Girolando cows got 15 mg phenylcapsaicin per day per cow (which corresponds to approximately 0.8 mg/kg of dry matter for this type of cattle) in their feed mix during a period of five weeks. This supplementation resulted in an average increase in milk yield of some 2 liters per day, representing an approximate 5% improvement in productivity.

To confirm the results of the exploratory field trial, a 90-day controlled randomized study was initiated to evaluate aXiphen® in Jersey dairy cows. A group of 28 cows received 1 g aXiphen®/day in their feed mix, while the control group was fed their standard feed. The study confirmed the previous results.

About the market
In 2024 Brazil was ranked the fifth largest milk producer in the world (www.ourworldindata.org), and some 80% of the country's milk production comes from Girolando cows. Girolando is a breed that is known for its ability to cope with the regional differences and seasonal changes in heat and humidity in the country, conditions that significantly impacts the milk yield. The average milk yield for Girolando cows in Brazil is approximately 17 liters per day (Embrapa Dairy Cattle, 2015, www.semadesc.ms.gov.br), which is in the lower span compared to other leading milk producing countries in the world. This means that milk producers in Brazil strive to increase the milk yield per cow, leveraging for example new technology and innovations in feed mix.

About phenylcapsaicin and aXiphen®
The health benefits of chili, with its active ingredient capsaicin have been known for centuries. aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, bridged by a triple bond. The result is an innovative natural analogue capsaicin with high purity, where the pungency is greatly reduced.
Production tests and studies have proven the effectiveness of aXiphen® as an ingredient in poultry feed. A production test on on-floor salmonella prevalence, following the inclusion of 15 ppm phenylcapsaicin in a regular starter diet, was carried out in a full-scale commercial broiler production trial under farming conditions. The production test included about 1.6 million broiler chickens. The trial concluded that under the conditions of the test, the inclusion of 15 ppm phenylcapsaicin in broiler chicken feed statistically significantly reduced the number of farms with salmonella-positive floor boot swabs. The European model for production efficiency, EPEF, showed that production efficiency increased by 14% compared to traditional feeding.

This information is such that aXichem is obliged to make public according to the EU's market abuse regulation (EU no. 596/2014). The information was submitted, through the provision of the specified contact person, for publication on 18 March 2026, 08:30 AM CET.

Company contact:
Torsten Helsing, CEO, aXichem AB
Phone: +46 706 863 355
Email: torsten.helsing@axichem.com

About aXichem
aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB.
More information is available at
www.axichem.com.